Multi-disciplinary patient-centered model for the expedited provision of costly therapies in community settings: the case of new medication for hepatitis C

Multi-disciplinary patient-centered model for the expedited provision of costly therapies in community settings: the case of new medication for hepatitis C

Abstract Background In January 2015, the first interferon-free direct-acting antiviral (DAA) therapy for chronic hepatitis C virus (HCV) infection was approved for inclusion in Israel’s national basket of health services. During 2015, HCV genotype 1 patients with advanced liver fibrosis (stage F3-F4...

Full description

Bibliographic Details
Main Authors: Nitzan Avisar, Yael Heller, Clara Weil, Aviva Ben-Baruch, Shani Potesman-Yona, Ran Oren, Gabriel Chodick, Varda Shalev, Nachman Ash
Format: Article
Language:English
Published: BMC 2017-09-01
Series:Israel Journal of Health Policy Research
Subjects:
Hepatitis C virus (HCV)
Direct-acting antiviral (DAA) therapy
Health care delivery
Access
Health services management –primary care
Patient-centered care
Online Access:http://link.springer.com/article/10.1186/s13584-017-0172-1

Internet

http://link.springer.com/article/10.1186/s13584-017-0172-1

Similar Items